190 related articles for article (PubMed ID: 25405202)
21. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
[TBL] [Abstract][Full Text] [Related]
22. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma.
Ueda M; Shimada T; Goto Y; Tei K; Nakai S; Hisa Y; Kannagi R
Auris Nasus Larynx; 2010 Aug; 37(4):488-95. PubMed ID: 20036791
[TBL] [Abstract][Full Text] [Related]
23. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
24. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.
Shi M; Chen D; Yang D; Liu XY
J Exp Clin Cancer Res; 2015 Dec; 34():149. PubMed ID: 26667143
[TBL] [Abstract][Full Text] [Related]
25. Upregulated miR‑20a‑5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21.
Wu H; Pang P; Liu MD; Wang S; Jin S; Liu FY; Sun CF
Oncol Rep; 2018 Aug; 40(2):1138-1146. PubMed ID: 29901115
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.
Liu Y; Yu C; Qiu Y; Huang D; Zhou X; Zhang X; Tian Y
J Cancer Res Clin Oncol; 2012 Feb; 138(2):195-202. PubMed ID: 22086185
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling.
Xu Y; Zhang Q; Zhou J; Li Z; Guo J; Wang W; Wang W
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189744
[TBL] [Abstract][Full Text] [Related]
29. Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck.
Zhang Z; Liu F; Li Z; Wang D; Li R; Sun C
Oncol Lett; 2017 May; 13(5):3191-3197. PubMed ID: 28521425
[TBL] [Abstract][Full Text] [Related]
30. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.
Sen B; Peng S; Woods DM; Wistuba I; Bell D; El-Naggar AK; Lai SY; Johnson FM
Clin Cancer Res; 2012 Jan; 18(1):127-39. PubMed ID: 22090359
[TBL] [Abstract][Full Text] [Related]
31. PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck.
Zhen-jin Z; Peng L; Fa-yu L; Liyan S; Chang-fu S
Mol Cell Biochem; 2011 Nov; 357(1-2):181-7. PubMed ID: 21735098
[TBL] [Abstract][Full Text] [Related]
32. Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.
Wang J; Zhang X; Thomas SM; Grandis JR; Wells A; Chen ZG; Ferris RL
Oncogene; 2005 Sep; 24(38):5897-904. PubMed ID: 16007209
[TBL] [Abstract][Full Text] [Related]
33. Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck.
Liu FY; Zhao ZJ; Li P; Ding X; Zong ZH; Sun CF
Br J Oral Maxillofac Surg; 2010 Jun; 48(4):291-6. PubMed ID: 19615795
[TBL] [Abstract][Full Text] [Related]
34. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype.
Wang J; Xi L; Hunt JL; Gooding W; Whiteside TL; Chen Z; Godfrey TE; Ferris RL
Cancer Res; 2004 Mar; 64(5):1861-6. PubMed ID: 14996750
[TBL] [Abstract][Full Text] [Related]
35. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
36. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
[TBL] [Abstract][Full Text] [Related]
37. CCR7 mediates inflammation-associated tumor progression.
Mburu YK; Wang J; Wood MA; Walker WH; Ferris RL
Immunol Res; 2006; 36(1-3):61-72. PubMed ID: 17337767
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ
Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754
[TBL] [Abstract][Full Text] [Related]
40. Frizzled2 mediates the migration and invasion of human oral squamous cell carcinoma cells through the regulation of the signal transducer and activator of transcription-3 signaling pathway.
Zhang E; Li Z; Xu Z; Duan W; Sun C; Lu L
Oncol Rep; 2015 Dec; 34(6):3061-7. PubMed ID: 26398330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
